01 / 23

Allosteric Regulation
& Cooperative Binding

Explore how enzymes and proteins are regulated by molecules binding at sites other than the active site, and how cooperative binding creates a sigmoidal response in multi-subunit proteins.

Biochemistry

What Is Allosteric Regulation?

Allosteric regulation occurs when a regulatory molecule binds to an enzyme at a site distinct from its active site, called the allosteric site. This binding changes the enzyme's three-dimensional shape, which alters its catalytic activity: either increasing it (activation) or decreasing it (inhibition).

Active Site vs. Allosteric Site

S E Active Site Allosteric Site Enzyme E S Activated Enzyme Conformational Change

Why Does Allosteric Regulation Matter?

★ Metabolic Control
Cells use allosteric regulation to fine-tune metabolic pathways, turning enzymes up or down in response to changing conditions.
★ Rapid Response
Unlike gene regulation (minutes to hours), allosteric effects are instantaneous: the enzyme changes activity the moment the effector binds.
★ Drug Targets
Many pharmaceuticals are designed as allosteric modulators, offering more specific targeting with fewer side effects than active-site drugs.

The T-State and R-State Model

Allosteric proteins exist in an equilibrium between two conformational states:

T-State (Tense)
Low affinity for substrate. The protein's binding sites are partially closed or constrained. This is the less active form.
R-State (Relaxed)
High affinity for substrate. The protein's binding sites are open and accessible. This is the more active form.

What Is Cooperative Binding?

Cooperative binding is a special case of allosteric regulation in multi-subunit proteins. When a ligand binds to one subunit, it induces a conformational change that increases the affinity of neighboring subunits for the same ligand.

Empty 1 bound 2 bound Saturated Progressive Binding Increases Affinity Each binding event makes the next one easier

The Hill Equation

Cooperative binding is quantified by the Hill equation, which describes the fraction of binding sites occupied (\(\theta\)) as a function of ligand concentration (\([L]\)):

\(n_H > 1\)
Positive cooperativity: binding of one ligand increases affinity for the next.
\(n_H = 1\)
No cooperativity: each binding event is independent (Michaelis-Menten behavior).
\(n_H < 1\)
Negative cooperativity: binding of one ligand decreases affinity for the next.

Sigmoidal vs. Hyperbolic Curves

[Ligand] Fractional Saturation (θ) 1.0 0.5 Cooperative (sigmoidal) Non-cooperative (hyperbolic)

Hemoglobin: The Classic Example

Hemoglobin is a tetramer (4 subunits), each carrying a heme group that binds \(\text{O}_2\). When the first \(\text{O}_2\) binds, it shifts that subunit from the T-state to the R-state, pulling neighboring subunits along. This makes each subsequent \(\text{O}_2\) bind more easily.

1
First \(\text{O}_2\) binds with the lowest affinity (T-state dominates).
2
Conformational change propagates to adjacent subunits, shifting equilibrium toward R-state.
3
Second and third \(\text{O}_2\) bind with increasing affinity.
4
Fourth \(\text{O}_2\) binds with the highest affinity: the protein is fully in the R-state.

Activators vs. Inhibitors

Allosteric Activator Allosteric Inhibitor
Binds to Allosteric site Allosteric site
Stabilizes R-state (relaxed) T-state (tense)
Effect on \(V_{\text{max}}\) May increase May decrease
Effect on \(K_m\) (or \(K_{0.5}\)) Decreases (higher affinity) Increases (lower affinity)
Curve shift Left shift Right shift
Example AMP on PFK-1 ATP on PFK-1

MWC vs. KNF Models

MWC (Concerted)
All subunits switch between T and R states simultaneously. No mixed states exist: the protein is entirely T or entirely R. Ligand binding shifts the equilibrium.
KNF (Sequential)
Each subunit changes individually upon ligand binding. Neighboring subunits are influenced progressively. Mixed conformations (some T, some R) are allowed.

Feedback Inhibition in Pathways

One of the most important applications of allosteric regulation is feedback inhibition: the end product of a metabolic pathway acts as an allosteric inhibitor of an enzyme early in the pathway.

A Enzyme 1 (allosteric) B C Product Feedback Inhibition

How to Analyze Cooperative Binding

1
Identify the protein: Is it a multi-subunit protein (like hemoglobin) or a single-subunit enzyme?
2
Examine the binding curve: Is it sigmoidal (cooperative) or hyperbolic (non-cooperative)?
3
Determine \(n_H\): Use a Hill plot (\(\log(\frac{\theta}{1-\theta})\) vs. \(\log([L])\)). The slope at half-saturation gives \(n_H\).
4
Identify effectors: Does any molecule shift the curve left (activator) or right (inhibitor)?
5
Apply the model: Use MWC for concerted transitions or KNF for sequential changes.

Example 1: \(\text{O}_2\) Binding to Hemoglobin

At low \(p\text{O}_2\) (such as in tissues at ~40 mmHg), hemoglobin is approximately 75% saturated. At high \(p\text{O}_2\) (lungs at ~100 mmHg), saturation is approximately 98%. This steep transition allows hemoglobin to load oxygen in the lungs and release it efficiently in the tissues.

\(p\text{O}_2\) (mmHg) % Saturation 0 20 40 60 80 100 0 50 100 Tissues Lungs Hemoglobin Myoglobin

Example 2: PFK-1 in Glycolysis

Phosphofructokinase-1 (PFK-1) is the key regulatory enzyme in glycolysis. It catalyzes the conversion of fructose-6-phosphate to fructose-1,6-bisphosphate.

Activators
AMP and fructose-2,6-bisphosphate bind allosterically, stabilizing the R-state. They signal that the cell needs more ATP.
Inhibitors
ATP (at high concentrations) and citrate bind allosterically, stabilizing the T-state. They signal that energy is abundant.

Example 3: Reading a Hill Plot

The Hill plot linearizes the binding equation. Plotting \(\log\left(\frac{\theta}{1-\theta}\right)\) vs. \(\log([L])\) gives a line whose slope at half-saturation equals \(n_H\).

\(\log([L])\)
\(\log(\frac{\theta}{1-\theta})\)
 0 \(n_H = 2.8\) \(n_H = 1\) \(n_H = 0.5\) \(\theta = 0.5\) line

Common Mistakes

✕ Confusing Allosteric with Competitive
Allosteric effectors bind at a different site, not the active site. Competitive inhibitors bind the active site directly.
✕ Assuming \(n_H\) = Number of Subunits
The Hill coefficient is an interaction coefficient, not the number of binding sites. Hemoglobin has 4 subunits but \(n_H \approx 2.8\).
✕ Forgetting T/R Equilibrium
In the MWC model, both states always exist in equilibrium. Effectors shift the balance; they don't create new states.

Summary Comparison

Non-Cooperative Positive Cooperativity Negative Cooperativity
Hill Coefficient \(n_H = 1\) \(n_H > 1\) \(n_H < 1\)
Binding Curve Hyperbolic Sigmoidal Flattened
Effect of 1st Ligand None on others Increases affinity Decreases affinity
Classic Example Myoglobin Hemoglobin Some enzymes
Model Michaelis-Menten MWC / KNF KNF only

Question 1 of 5

An allosteric inhibitor binds to an enzyme and stabilizes the T-state. What effect does this have on the enzyme's substrate affinity?

Question 2 of 5

Hemoglobin has a Hill coefficient of approximately \(n_H \approx 2.8\). What does this value indicate?

Question 3 of 5

In feedback inhibition, which statement is correct?

Question 4 of 5

How does the MWC (concerted) model differ from the KNF (sequential) model of allosteric regulation?

Question 5 of 5

Myoglobin displays a hyperbolic oxygen-binding curve, while hemoglobin displays a sigmoidal curve. Which best explains why hemoglobin is a more effective oxygen transporter?